Strata Critical Medical (SRTA)

Its model is built around an integrated “One Call” service designed to simplify a highly complex process. Organ transplantation involves narrow medical windows, multiple clinical teams, aviation or ground transport, regulatory requirements, and real-time decision-making. Strata Critical Medical seeks to bring these elements together through a network that supports donor organ movement, recovery procedures, preservation, and related services.

The company operates through logistics and clinical activities. The logistics side includes air transportation, ground logistics, and organ placement support, helping move organs, personnel, and equipment where they are needed. The clinical segment includes organ recovery services, normothermic regional perfusion, preservation support, cardiac care, and other medical services associated with transplant and critical-care workflows.

Strata Critical Medical serves a specialised part of healthcare infrastructure where reliability, response time, and coordination can directly affect patient outcomes. Its business is shaped by transplant volumes, relationships with hospitals and organ procurement organisations, fleet and network capacity, reimbursement dynamics, and the adoption of advanced preservation and perfusion techniques. As a public company, it offers investors exposure to the operational backbone of organ transplantation rather than to a traditional hospital, insurer, or medical device manufacturer.